Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

FUE hair transplantation is safe and effective for improving hair loss in children.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Adding nano fat to hair transplants improves results for scar-related hair loss.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

There is no standard treatment for CCCA, and practices vary widely.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Brunsting-Perry pemphigoid can cause scarring hair loss and may be underdiagnosed.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Widened sweat ducts are a very specific sign of scarring hair loss.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.